97 related articles for article (PubMed ID: 1468211)
1. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
[TBL] [Abstract][Full Text] [Related]
2. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
5. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
Shih MH; Huang FC
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
[TBL] [Abstract][Full Text] [Related]
6. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model.
Paschal JF; Holland GN; Sison RF; Berlin OG; Bruckner DA; Dugel PU; Foos RY
Cornea; 1992 Nov; 11(6):493-9. PubMed ID: 1468210
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
[TBL] [Abstract][Full Text] [Related]
10. Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
Pacheco PA; Tam PM
J Cataract Refract Surg; 2010 May; 36(5):843-6. PubMed ID: 20457379
[TBL] [Abstract][Full Text] [Related]
11. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
[TBL] [Abstract][Full Text] [Related]
12. Combination drug testing of Mycobacterium chelonae.
Matoba AY; Lee BL; Robinson NM; Penland R; Osato MS
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2786-9. PubMed ID: 8344799
[TBL] [Abstract][Full Text] [Related]
13. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model.
Hu FR; Wang IJ
Curr Eye Res; 1998 May; 17(5):478-82. PubMed ID: 9617541
[TBL] [Abstract][Full Text] [Related]
16. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Hu FR; Luh KT
Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
[TBL] [Abstract][Full Text] [Related]
17. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
Karicherla P; Hobden JA
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
[TBL] [Abstract][Full Text] [Related]
18. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
[TBL] [Abstract][Full Text] [Related]
20. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
